SK284838B6 - Farmaceutický prípravok obsahujúci levosimendán a použitie levosimendánu na výrobu lieku - Google Patents

Farmaceutický prípravok obsahujúci levosimendán a použitie levosimendánu na výrobu lieku Download PDF

Info

Publication number
SK284838B6
SK284838B6 SK906-2000A SK9062000A SK284838B6 SK 284838 B6 SK284838 B6 SK 284838B6 SK 9062000 A SK9062000 A SK 9062000A SK 284838 B6 SK284838 B6 SK 284838B6
Authority
SK
Slovakia
Prior art keywords
levosimendan
pharmaceutically acceptable
medicament
acceptable salt
mucoadhesive
Prior art date
Application number
SK906-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK9062000A3 (en
Inventor
Kauko Kurkela
Martti Marvola
Ilkka Larma
Raimo Virtanen
Marianne Karlsson
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SK9062000A3 publication Critical patent/SK9062000A3/sk
Publication of SK284838B6 publication Critical patent/SK284838B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Air Bags (AREA)
  • Luminescent Compositions (AREA)
SK906-2000A 1997-12-19 1998-12-11 Farmaceutický prípravok obsahujúci levosimendán a použitie levosimendánu na výrobu lieku SK284838B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974578A FI974578A (fi) 1997-12-19 1997-12-19 Menetelmä levosimendaanin antamiseksi
PCT/FI1998/000977 WO1999032081A1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Publications (2)

Publication Number Publication Date
SK9062000A3 SK9062000A3 (en) 2000-12-11
SK284838B6 true SK284838B6 (sk) 2005-12-01

Family

ID=8550178

Family Applications (1)

Application Number Title Priority Date Filing Date
SK906-2000A SK284838B6 (sk) 1997-12-19 1998-12-11 Farmaceutický prípravok obsahujúci levosimendán a použitie levosimendánu na výrobu lieku

Country Status (26)

Country Link
US (1) US6399610B1 (hu)
EP (1) EP1052973B1 (hu)
JP (1) JP2001526205A (hu)
KR (1) KR100753689B1 (hu)
AT (1) ATE215358T1 (hu)
AU (1) AU738082B2 (hu)
BR (1) BR9813641A (hu)
CA (1) CA2313618C (hu)
CZ (1) CZ296693B6 (hu)
DE (1) DE69804678T2 (hu)
DK (1) DK1052973T3 (hu)
EA (1) EA002197B1 (hu)
EE (1) EE04330B1 (hu)
ES (1) ES2175827T3 (hu)
FI (1) FI974578A (hu)
HR (1) HRP20000400B1 (hu)
HU (1) HU226736B1 (hu)
IL (1) IL136415A (hu)
NO (1) NO320050B1 (hu)
NZ (1) NZ504806A (hu)
PL (1) PL191868B1 (hu)
PT (1) PT1052973E (hu)
RS (1) RS49889B (hu)
SK (1) SK284838B6 (hu)
WO (1) WO1999032081A1 (hu)
ZA (1) ZA9811405B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP1848270B1 (en) * 2005-02-17 2014-05-21 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
CN101516426A (zh) 2006-09-27 2009-08-26 尼克诺姆股份公司 定向用途
US11523986B2 (en) * 2019-03-22 2022-12-13 Dbbh, Llc Intranasally administered antihistamines and uses thereof
WO2021001601A1 (en) * 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
HUP0100452A3 (en) 2002-03-28
IL136415A (en) 2005-03-20
ZA9811405B (en) 1999-06-11
AU1565699A (en) 1999-07-12
EA002197B1 (ru) 2002-02-28
FI974578A0 (fi) 1997-12-19
CZ296693B6 (cs) 2006-05-17
CA2313618C (en) 2008-02-05
DE69804678D1 (de) 2002-05-08
EE04330B1 (et) 2004-08-16
WO1999032081A1 (en) 1999-07-01
NO20003059L (no) 2000-06-14
NO20003059D0 (no) 2000-06-14
EP1052973A1 (en) 2000-11-22
ATE215358T1 (de) 2002-04-15
HRP20000400B1 (en) 2009-06-30
YU36900A (sh) 2003-02-28
PL191868B1 (pl) 2006-07-31
DE69804678T2 (de) 2002-11-21
HUP0100452A2 (hu) 2002-02-28
CZ20002155A3 (cs) 2000-11-15
KR100753689B1 (ko) 2007-08-30
KR20010033368A (ko) 2001-04-25
BR9813641A (pt) 2000-10-17
JP2001526205A (ja) 2001-12-18
NO320050B1 (no) 2005-10-17
EP1052973B1 (en) 2002-04-03
PT1052973E (pt) 2002-09-30
RS49889B (sr) 2008-08-07
NZ504806A (en) 2001-09-28
ES2175827T3 (es) 2002-11-16
AU738082B2 (en) 2001-09-06
HU226736B1 (en) 2009-08-28
CA2313618A1 (en) 1999-07-01
IL136415A0 (en) 2001-06-14
FI974578A (fi) 1999-06-20
EE200000368A (et) 2001-10-15
US6399610B1 (en) 2002-06-04
DK1052973T3 (da) 2002-04-29
SK9062000A3 (en) 2000-12-11
HRP20000400A2 (en) 2000-12-31
EA200000686A1 (ru) 2000-12-25
PL341202A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
KR100498646B1 (ko) 경구용 펩티드 약학적 조성물
US4788221A (en) Pharmaceutical compositions comprising calcitonin and an absorption-promoting substance
Bhati et al. A detailed review on oral mucosal drug delivery system
Nagai et al. Buccal delivery systems using hydrogels
US6210699B1 (en) Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US5863555A (en) Buccal delivery of glucagon-like insulinotropic peptides
CA2446712C (en) System for osmotic delivery of pharmaceutically active agents
CN1159950A (zh) 控制活性成分释放的生物粘合药物组合物
WO2002020037A1 (fr) Composition pharmaceutique a administration orale liberee au niveau colique
TW201043280A (en) Pharmaceutical system for trans-membrane delivery
WO2004110445A1 (ja) フェンタニル含有口腔粘膜貼付剤
TW200940107A (en) Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
SK284838B6 (sk) Farmaceutický prípravok obsahujúci levosimendán a použitie levosimendánu na výrobu lieku
WO2010126818A1 (en) Intranasal delivery system for dantrolene
EP1652523A1 (en) Transdermal absorption preparation
Datir Recent advances in mucoadhesive buccal drug delivery system and its marketed scope and opportunities
US20050118241A1 (en) Platform for transdermal formulations (ptf)
JPS63250318A (ja) 口腔内に適用する製剤
EA002023B1 (ru) Фармацевтическая композиция местного применения для введения в живой организм, содержащая пептидное лекарственное средство
MXPA00006027A (en) Transmucosal formulations of levosimendan
WO2001064253A1 (fr) Compositions medicinales renfermant un agent modificateur de la glycoproteine p pour administration au gros intestin

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20101211